Innovation in Design and Acquisition for Compound Screening Libraries

  • Author/Organiser: Society of Chemical Industry (SCI)'s Fine Chemicals Group and the Academic Drug Discovery Consortium (ADDC)
  • Event Website:
  • Event Date: 15 May 2018 to 15 May 2018
  • Event Type: Conference
  • Venue: Benjamin Franklin Institute of Technology, Boston, MA, USA
  • Associated Societies: Society of Chemical Industry (SCI), UK

View Full Event Details

The symposium seeks to explore the question of what to include in a virtual, high-throughput, or fragment-based screen and create a dynamic, interactive environment for discussion of this important topic. It is critical to understand the current design and selection methods of compound screening libraries, along with the range of available business models for library acquisition and enhancement.

The conference should appeal to medicinal chemists, synthetic chemists, computational chemists, and compound management teams from industry and academia involved in library design and acquisition, along with those involved in hit and lead generation primarily in drug discovery and agrochemistry.

The event will include talks on computational design, focused library sets for phenotypic screening, 3-d fragment libraries, attention to physicochemical properties, opportunities from advances in synthetic organic chemistry as well as the compound acquisition market place.

Selected Speakers

  • From simple mixtures to DNA encoded libraries: A 40-year journey
    Aubrey Mendonca, Chemroutes
  • Post screening triage processes: quality-driven hit prioritisation
    Heather Tye, Evotec
  • Novel natural product-based Macrocyclic platform: macroevolution
    Dietmar Wolf, AnalytiCon
  • DNA-encoded library: Diversity via Building blocks and scaffolds
    Yun Ding, GlaxoSmithKline
  • Accessing new chemical space through flow technology for early phase drug discovery
    Balázs Gyimóthy, CominnexZrt
  • Evolution of the AstraZeneca screening library
    Dean Brown, AstraZeneca
  • Discovery of novel chemistry for new biology from within a billion compounds you can buy in 6 weeks
    John Irwin, University of California, San Francisco
  • Ajit Jadav, NIH/NCATS
  • Nicholas Skelton, Genentech
  • Steven LaPlante, Nmxresearch, Visiting scientist at the Broad Institute and Institute Pasteur
  • Lori Ferrins; North Eastern University
  • Caroline Shamu, Harvard

Organizing Committee

  • Jayshree Mistry, SCI
  • Aubrey Mendonca, Chemroutes
  • Yun Ding, GlaxoSmithKline
  • Stephen Frye, UNC
  • Michelle Arkin, UCSF


Article Views: 320

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH